Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 188

Results For "NCEs"

2679 News Found

‘SMART’ program for Ayurveda professionals to boost research in Ayurveda
Policy | January 03, 2023

‘SMART’ program for Ayurveda professionals to boost research in Ayurveda

The proposed initiative is conceptualised with an objective to identify, support, and promote innovative research ideas in healthcare research


Survival Technologies files DRHP with SEBI for Rs 1,000 crore IPO
News | January 02, 2023

Survival Technologies files DRHP with SEBI for Rs 1,000 crore IPO

The company is one of the most profitable companies manufacturing speciality chemicals in India


Zydus receives final approval from USFDA for Triazolam Tablets
Drug Approval | December 31, 2022

Zydus receives final approval from USFDA for Triazolam Tablets

Triazolam tablets are used on a short-term basis to treat insomnia (difficulty falling asleep or staying asleep)


Stelis Biopharma’s CDMO partner receives approval for key ANDA from the USFDA
Drug Approval | December 29, 2022

Stelis Biopharma’s CDMO partner receives approval for key ANDA from the USFDA

The current approval is first of the many fillings made by the company's CDMO partners from the flagship facility in Bangalore


Hester to develop low pathogenic avian influenza inactivated vaccine for poultry
News | December 29, 2022

Hester to develop low pathogenic avian influenza inactivated vaccine for poultry

The company has plans to launch this Vaccine by the end of 2023 after completing the required field studies and obtaining regulatory approvals


Amcor sells factories in Russia
Packaging | December 28, 2022

Amcor sells factories in Russia

The cash and debt free consideration value is €370 million.


MindRank gets USFDA clearance of IND application for MDR-001 for treatment of Type 2 diabetes
Drug Approval | December 27, 2022

MindRank gets USFDA clearance of IND application for MDR-001 for treatment of Type 2 diabetes

MindRank expects to initiate a Phase I safety study in the first quarter of 2023.


NAFLD clinical trial activity catching up in China but lacks substantial domestic participation, says GlobalData
News | December 27, 2022

NAFLD clinical trial activity catching up in China but lacks substantial domestic participation, says GlobalData

China has the highest number of clinical trials that were initiated in NAFLD in the APAC region over the past decade.


ESIC plans to fill 6,400 vacancies including posts for more than 2,000 doctors and teaching faculty: Bhupender Yadav
Policy | December 26, 2022

ESIC plans to fill 6,400 vacancies including posts for more than 2,000 doctors and teaching faculty: Bhupender Yadav

The organisation is also working towards providing skills based training programmes to the workers for paramedical jobs and has launched certificate courses in ten disciplines


Advent International to acquire a significant stake in Suven Pharmaceuticals
News | December 26, 2022

Advent International to acquire a significant stake in Suven Pharmaceuticals

Advent will also be making an open offer to acquire additional 26% of the outstanding equity shares of the company from the public shareholders.